What is this worth to SKTO? 10c? 25c? $1? The peer-reviewed

New Post Public Reply Private Reply Replies (1) Message Board
bellsandwhistles
What is this worth to SKTO? 10c? 25c? $1? The peer-reviewed British medical journal Lancet (British equivalent of JAMA ) has published a study linking coronary disease (#1 killer in US) to chronic inflammation. In fact, there is a growing body of thought and evidence in medical research that chronic inflammation may be the root cause of many diseases.

British journal "Lancet" has therefore supplied yet another strong reason why Dharmanol, with its array of
powerful anti-inflammatory ingredients that naturally quell physiological inflammation, may be a blockbuster product.


Lancet study:  http://www.thelancet.com/journals/laninf/arti...10)70029-3

Yahoo Health |
Inflammation: The Root Cause of All Disease?


"In a medical version of the 'unified field' theory in physics, many scientists now believe that most—or perhaps all—chronic diseases may have the same trigger: inflammation. This fiery process has been linked to everything from heart attacks and strokes to type 2 diabetes, Alzheimer’s disease, and even cancer. "

By Lisa Collier Cool
Jan 16, 2013

In a medical version of the “unified field” theory in physics, many scientists now believe that most—or perhaps all —chronic diseases may have the same trigger: inflammation. This fiery process has been linked to everything from heart attacks and strokes to type 2 diabetes, Alzheimer’s disease, and even cancer.

Chronic, low-grade systemic inflammation—fueled by such disorders as excessive belly fat, poor diet, lack of exercise, smoking, and gum disease—may explain why lifestyle-linked diseases have reached epidemic levels in Western countries, while remaining rare in the developing world.

“There are clear indications that inflammation explains why plaque builds up in the arteries in patients with atherosclerosis,” says Philip Schauer, MD, director of the Bariatric and Metabolic Institute at the Cleveland Clinic. “Chronic inflammation also plays a direct role in diabetes, high blood pressure, sleep apnea, asthma and many other conditions.”

The Missing Puzzle Piece

Two groundbreaking new studies published in Lancet suggest that fire inside the artery walls could be the missing puzzle piece to solve the mystery of why many people with normal or even optimal cholesterol levels suffer heart attacks or strokes, while others with very high cholesterol never develop heart disease.

The studies were the first to show a cause-and-effect relationship between a specific inflammatory marker (interleukin 6, also known as IL-6) and heart disease risk—a discovery that could lead to revolutionary new therapies to treat or prevent the leading killer of Americans.

The researchers pooled data from nearly 135,000 people and found that those with a gene variant linked to a lower-than-normal number of IL-6 receptors were much less likely to develop heart disease, even though they had the same rates of smoking, diabetes, high cholesterol, and other risk factors as people without this variant.

The findings suggest that medication to block IL-6 receptors—currently used to treat rheumatoid arthritis (also an inflammatory disease)—could be a new weapon against heart disease.

Is Your Body on Fire?

Most of the time, inflammation protects health. If you stepped on a nail, your body would mobilize immune system troops to battle the invading bacteria by releasing signaling molecules, such as IL-6, to launch the inflammatory cascade. The immune system reaction involves more than 20 proteins that blast the invaders with chemicals to kill them, along with an assortment of odd-looking white blood cell components that resemble characters from Creepshow2.

The result of this immune system response is the familiar feeling of redness and warmth around the wound as it starts to heal. Chronic inflammation, however, harms rather than heals, because the immune system attack never stops. It’s like being shot by “friendly fire” during a perpetual war raging inside the body, says Dr. Schauer.

The #1 Warning Sign of Chronic Inflammation

The easiest way to tell if your body—and arteries—might be on fire is to measure your waist. A circumference above 35 inches for a woman or 40 inches for a man means you could be at risk for a variety of dangerous diseases linked to chronic inflammation, even if your weight is normal.

“Excessive visceral fat is very different than fat in other parts of the body,” says Dr. Schauer. “Abdominal fat cells are much more biologically active than subcutaneous fat cells, releasing several hormones and cytokines [chemical messengers involved in immune system and inflammatory responses]. There is also a genetic component to both chronic inflammation and obesity—it’s not just an unhealthy lifestyle that leads to these problems.”

A big belly is also the leading indicator of metabolic syndrome, a gang of five metabolic thugs that quintuple risk for type 2 diabetes and triple it for heart attack. Fifty million Americans, many of whom are undiagnosed, suffer from this dangerous disorder.

If you have three or more of the following disorders, you have metabolic syndrome:

A large waistline. This also is called "an apple shape."
High triglycerides: a level of this blood fat above 150 mg/dL
Low HDL (less than 50 mg/dL for women and less than 40 mg/dL for men). HDL is the good cholesterol that keeps the heart and brain healthy.
High blood pressure: 130/85 mmHg or higher (or you’re on blood pressure medicine).
High fasting blood sugar: 100 mg/dL or above  (or you're on medicine to treat high blood sugar).

Can Targeting Inflammation Improve Alzheimer’s Disease?

Many studies have linked Alzheimer’s disease—also called “type 3 diabetes”—to chronic inflammation. A new study published in Nature Medicine reports that in mice with the memory-robbing disorder, levels of pro-inflammatory cytokines called IL-12 and IL-23 soar.

When the animals’ brains were treated with antibodies that target IL-12 and Il-23, their memory deficits were actually “reversed,” the researchers report, suggesting that anti-inflammatory therapies may help combat the disease’s progression.

Another new study found that statins—which are known to have potent anti-inflammatory effects in people—boosted memory in mice in the early stages of Alzheimer’s. The statin used in the study was simvastin (Zocor).

However, medication isn’t the only fire-fighter; research also shows that regular exercise helps keep both the body and brain healthy. Interval training, in particular, is one of the best ways to slim your waist—and put out the fire in your belly.
http://health.yahoo.net/experts/dayinhealth/i...ll-disease

SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading